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ABSTRACT 
Cervical cancer is one of the leading causal cancer-related fatalities in the world. Cervical 
cancer patients can be treated by conventional treatment such as surgery, radiotherapy, 
chemotherapy, medications and combination treatments. Currently, more targeted treatments 
are being developed to cure cervical cancer. The treatments include immunotherapy, 
virotherapy and gene therapy which will be discussed in this paper. In immunotherapy, the 
synergy of CTLA-4 suppression and PD-1/PDL-1 immune checkpoint inhibition targeting 
their corresponding pathways enhanced the human immune system resulting a promising 
treatment effects. Oncolytic viruses such as Newcastle disease virus selectively infect and kill 
cancerous cells/tissues without harming normal cells/tissues. This character has made them a 
potential modality in combating cancer which popularly known as oncolytic virotherapy. 
Gene therapy delivers modified genetic materials to the target cancer cells via viral and non-
viral vectors. It is used to target the abnormal gene, to increase cells’ susceptibility towards 
drugs or conventional therapy, to induce tumour cells apoptosis, to enhance tumour cell 
immunogenicity recognition and to inhibit the oncogene expression. The objective of this 
minireview is to add to the general knowledge on aforementioned therapeutic strategies 
against cervical cancer. 
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